Xencor | XNCR - Gross Profit On Sales


Xencor reported $51.22M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
AbbVie USD 14.39B 1.85B Jun/2026
Alnylam Pharmaceuticals USD 992.69M 167.68M Jun/2026
Amgen USD 5.87B 1.02B Mar/2026
Arrowhead Research USD 73.74M 190.3M Mar/2026
AstraZeneca USD 12.86B 251M Jun/2026
Biogen USD 2.12B 307M Jun/2026
Bristol-Myers Squibb USD 9.26B 1.19B Jun/2026
Cytokinetics USD 23.03M 3.84M Jun/2026
GlaxoSmithKline GBP 6.51B 757M Jun/2026
J&J USD 18.55B 1.31B Jun/2026
Karyopharm Therapeutics USD 33.72M 1.13M Mar/2026
MacroGenics USD 11.24M 19.87M Mar/2026
Merck USD 12.09B 1.24B Mar/2026
Novartis USD 11.24B 1.18B Jun/2026
Pfizer USD -248M 11.29B Jun/2026
Regeneron Pharmaceuticals USD 3.71B 778.2M Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
Xencor USD 51.22M 46.7M Jun/2026